000			01589 a2200397 4500
005			20250516043433.0
264		0	_c20120117
008			201201s 0 0 ger d
022			_a1437-1588
024	7		_a10.1007/s00103-011-1308-z _2doi
040			_aNLM _beng _cNLM
100	1		_aWalter, C
245	0	0	_a[Regulatory framework of innovative therapies : From bench to bedside]. _h[electronic resource]
260			_bBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz _cJul 2011
300			_a803-10 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aBiotechnology _xlegislation & jurisprudence
650	0	4	_aClinical Trials as Topic _xlegislation & jurisprudence
650	0	4	_aDrugs, Investigational _xtherapeutic use
650	0	4	_aGenetic Therapy _xlegislation & jurisprudence
650	0	4	_aGermany
650	0	4	_aGuidelines as Topic
650	0	4	_aHumans
650	0	4	_aNational Health Programs _xlegislation & jurisprudence
650	0	4	_aStem Cell Transplantation _xlegislation & jurisprudence
650	0	4	_aTherapies, Investigational
650	0	4	_aTissue Engineering _xlegislation & jurisprudence
650	0	4	_aTranslational Research, Biomedical _xlegislation & jurisprudence
700	1		_aRohde, B
700	1		_aWicke, D C
700	1		_aPohler, C
700	1		_aLührmann, A
700	1		_avon der Leyen, H
773	0		_tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz _gvol. 54 _gno. 7 _gp. 803-10
856	4	0	_uhttps://doi.org/10.1007/s00103-011-1308-z _zAvailable from publisher's website
999			_c20952576 _d20952576